Long‐term Oncologic Results and Voice Outcomes in Patients With Glottic Cancer After Modified Type III Cordectomy
Authors:
- 15 February 2022
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 167 (5) , 839-845
Abstract
Objective Transoral laser microsurgery and radiotherapy provide high and comparable cure rates for the treatment of early glottic cancer. However, the voice outcomes after treatment remain controversial. A modified type III cordectomy technique was proposed in 2006, and preliminary results showed it to be an oncologically safe method with satisfactory voice outcomes. This study aimed to evaluate oncologic and voice outcomes after long-term follow-up of these patients. Study Design Retrospective cohort study. Setting Tertiary care academic center. Methods Between 2006 and 2018, 42 patients with glottic cancer underwent a modified type III cordectomy. This technique resected the tumor and upper part of the vocal folds and preserved the lower part of the vocalis muscle as a scaffold to improve glottis closure. The oncologic results and voice outcomes were evaluated at a median follow-up of 68 months. Results The primary tumor stages included 13 T1 (31%), 26 T2 (64%), and 3 T3 (7%). Eight patients (19%) had local recurrence, and 6 underwent successful salvage with transoral laser microsurgery with or without postoperative radiotherapy with laryngeal preservation. The 5-year rate of local control was 80%; laryngeal preservation, 95%; overall survival, 89%; and disease-specific survival, 97%. The final laryngeal preservation rate was 95% (40/42). The voice outcomes were satisfactory and comparable to those of patients who underwent type I and II cordectomies. Conclusion The modified type III cordectomy has been proven to be an oncologically safe method with satisfactory voice outcomes after long-term follow-up in selected cases of early glottic cancer.Keywords
Funding Information
- Taipei Veterans General Hospital (V109C‐040)
This publication has 27 references indexed in Scilit:
- Modified type III cordectomy to improve voice outcomes after transoral laser microsurgery for early glottic canserHead & Neck, 2011
- Quality of life and functional outcomes in the management of early glottic carcinoma: a systematic review of studies comparing radiotherapy and transoral laser microsurgeryClinical Otolaryngology, 2010
- Voice quality after CO2 laser cordectomy—What can we really expect?Head & Neck, 2007
- Quality of life and voice in patients after laser cordectomy for TIS and T1 glottic carcinomasHead & Neck, 2007
- The role of laser microsurgery in the treatment of laryngeal cancerCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2007
- Functional Outcomes after CO2 Laser Treatment of Early Glottic CarcinomaThe Laryngoscope, 2006
- Management of T1–T2 glottic carcinomasCancer, 2004
- Voice Evaluation before and after Laser Excision vs. Radiotherapy of T1A Glottic CarcinomaActa Oto-Laryngologica, 1995
- Comparative Voice Results After Laser Resection or Irradiation of T1 Vocal Cord CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1994
- Results of curative laser microsurgery of laryngeal carcinomasAmerican Journal of Otolaryngology, 1993